Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Brisebois covers the Healthcare sector, focusing on stocks such as Savara, Praxis Precision Medicines, and Opus Genetics. According to TipRanks, Brisebois has an average return of 2.4% and a 40.11% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Savara with a $11.00 average price target.
Based on Savara’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $37.28 million. In comparison, last year the company had a GAAP net loss of $26.64 million
